About Index Trending news
Analyze
Top 50 Pricing
BioMarin Pharmaceutical

BioMarin Pharmaceutical

Work at BioMarin Pharmaceutical? Add yourself to this profile

BioMarin Pharmaceutical

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Elsewhere

Alexa global traffic share

Employees

Team size

1000+
Xconomy

Two Years After Paying $680M, BioMarin Shelves Duchenne Drug

The Motley Fool

BioMarin Pharmaceutical Inc.: Solid Earnings, Pipeline Progressing

The Motley Fool

The 5-Minute Guide to BioMarin Pharmaceutical Stock

Xconomy

BioMarin Heads to FDA With Mixed Data For Rare Disease Drug

Xconomy

Spurned in Duchenne, BioMarin Will Seek Approval For Batten Drug

The Motley Fool

BioMarin Pharmaceutical Inc. Ratchets Up the Profitability Talk

Stock markets
The Motley Fool

Will 2016 Be BioMarin Pharmaceutical's Best Year Yet?

Stock markets Health